Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.72 CNY
266.86 M CNY
3.62 B CNY
340.48 M
About PORTON PHARMA SOLU
Sector
CEO
Nian Feng Ju
Headquarters
Chongqing
Website
Founded
2005
ISIN
CNE100001S57
FIGI
BBG002Z7JSJ9
Porton Pharma Solutions Ltd. engages in the research, development and manufacture of pharmaceutical products and active pharmaceutical ingredients. It offers anti-viral, anti-diabetic, anti-hypertensive, anti-cancer, analgesic, hypolipidemic, and antibacterial drug treatment. The company was founded on July 7, 2005 and is headquartered in Chongqing, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 300363 is 17.20 CNY — it has decreased by −5.29% in the past 24 hours. Watch PORTON PHARMA SOLU stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange PORTON PHARMA SOLU stocks are traded under the ticker 300363.
300363 stock has fallen by −10.37% compared to the previous week, the month change is a 8.52% rise, over the last year PORTON PHARMA SOLU has showed a −41.32% decrease.
We've gathered analysts' opinions on PORTON PHARMA SOLU future price: according to them, 300363 price has a max estimate of 23.70 CNY and a min estimate of 20.00 CNY. Watch 300363 chart and read a more detailed PORTON PHARMA SOLU stock forecast: see what analysts think of PORTON PHARMA SOLU and suggest that you do with its stocks.
300363 reached its all-time high on Aug 5, 2021 with the price of 109.77 CNY, and its all-time low was 7.04 CNY and was reached on Oct 19, 2018. View more price dynamics on 300363 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
300363 stock is 6.16% volatile and has beta coefficient of 2.11. Track PORTON PHARMA SOLU stock price on the chart and check out the list of the most volatile stocks — is PORTON PHARMA SOLU there?
Today PORTON PHARMA SOLU has the market capitalization of 9.38 B, it has decreased by −1.52% over the last week.
Yes, you can track PORTON PHARMA SOLU financials in yearly and quarterly reports right on TradingView.
PORTON PHARMA SOLU is going to release the next earnings report on Mar 31, 2025. Keep track of upcoming events with our Earnings Calendar.
300363 net income for the last quarter is −36.39 M CNY, while the quarter before that showed −75.17 M CNY of net income which accounts for 51.58% change. Track more PORTON PHARMA SOLU financial stats to get the full picture.
Yes, 300363 dividends are paid annually. The last dividend per share was 0.49 CNY. As of today, Dividend Yield (TTM)% is 2.83%. Tracking PORTON PHARMA SOLU dividends might help you take more informed decisions.
PORTON PHARMA SOLU dividend yield was 1.94% in 2023, and payout ratio reached 99.67%. The year before the numbers were 2.71% and 29.90% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 24, 2024, the company has 4.92 K employees. See our rating of the largest employees — is PORTON PHARMA SOLU on this list?
Like other stocks, 300363 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PORTON PHARMA SOLU stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PORTON PHARMA SOLU technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PORTON PHARMA SOLU stock shows the sell signal. See more of PORTON PHARMA SOLU technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.